ETAP-LAB is an independent preclinical CRO that provides efficacy testing and pharmacology services to pharmaceutical, biotechnology and medtech companies.

ETAP-LAB has 35+ years of expertise with 4 services:
– BrainXplore: in vitro and in vivo models of Alzheimer, Parkinson, ALS, depression and anxiety.
– Stro@lliance: more than 10 models of both ischemic and hemorrhagic stroke.
– SkinAxis: inflammation models (psoriasis, atopic dermatitis,…) and wound healing (different shape, size, depth; skin grafting).
– SynCROsome: dedicated to Cardiology including HFpEF, HFrEF, Pulmonary Artery hypertension, Systemic hypertension, thrombosis.

ETAP-LAB’s services are designed to support drug discovery phases ranging from in vitro lead optimization to non-GLP animal testing (POC, PK/PD, non-regulatory safety pharmacology), to evaluate your drug candidates (small molecules, antibodies, cell therapies…) and medical devices.

ETAP LAB’s services rely on state of the art facilities and equipment, including high content imaging, in vivo imaging platforms (MRI, PET scan, echocardiography, dermoscopy), microsurgery capabilities, and comprehensive immunohistochemistry and bioassay readouts.